XTL BIOPHARMACEUTICALS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.48 USD | -7.29% |
|
+7.83% | +145.53% |
| Jun. 05 | XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy | MT |
| Jun. 05 | XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 46.55B | - | |||||
| 41.84B | ||||||
| 40.84B | ||||||
| 32.95B | - | |||||
| 28.27B |
